![Ranjit Bindra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ranjit S.
Bindra was the founder of Helix Therapeutics, Inc. as Director, founded in 2006.
Dr. Bindra was the founder of Cybrexa, Inc. as Scientific Advisor, founded in 2016.
Dr. Bindra is also the founder of Athena Therapeutics LLC,Modifi Biosciences, Inc. Former job at National Cancer Institute as Director.
Former job at Yale Corp.
as Principal.
| Unternehmen | Position | Ende |
|---|---|---|
Modifi Biosciences
 Modifi Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in developing therapeutics to treat cancer | Gründer | - |
Athena Therapeutics LLC
 Athena Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops drugs for metabolism defects in cancer | Gründer | - |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Gründer | - |
Yale Corp.
 Yale Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a local authority | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Yale Corp.
Yale Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a local authority | Commercial Services |
Helix Therapeutics, Inc.
 Helix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops DNA therapeutics for human genetic diseases | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
Athena Therapeutics LLC
Athena Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops drugs for metabolism defects in cancer | Health Technology |
Modifi Biosciences
Modifi Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in developing therapeutics to treat cancer | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
